Associated Papers
Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome.
Zhao Z et al.
Ebiomedicine, 2024
Blockade of the Human Ether A-Go-Go-Related Gene (hERG) Potassium Channel by Fentanyl.
Tschirhart JN et al.
Molecular Pharmacology, 2019
The Link between Inactivation and High-Affinity Block of hERG1 Channels.
Wu W et al.
Molecular Pharmacology, 2015
Current pharmacogenomic studies on hERG potassium channels.
He FZ et al.
Trends in Molecular Medicine, 2013
Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
Tu DN et al.
Sheng Li Xue Bao : [acta Physiologica Sinica], 2008
Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
Guo J et al.
The Journal of Pharmacology and Experimental Therapeutics, 2006
S641 contributes HERG K+ channel inactivation.
Bian JS et al.
Cell Biochemistry and Biophysics, 2004
Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.
Ficker E et al.
Molecular Pharmacology, 2001
Molecular determinants of dofetilide block of HERG K+ channels.
Ficker E et al.
Circulation Research, 1998
Select a paper to view details